Table 2.
Variable | n | % |
---|---|---|
Study | ||
Descriptive | 22 | 67 |
Case-control | 11 | 33 |
Population group | ||
Female | 6595 | 63 |
Male | 318 | 3 |
Kids | 293 | 3 |
Not specified | 3192 | 31 |
Sample | ||
B.M. | 1 | 2.6 |
BM & PB | 1 | 2.6 |
BTFFP | 19 | 50 |
Fresh breast tissue | 1 | 2.6 |
P.B./ Cell fraction | 8 | 21 |
P.B./ Serum | 5 | 13.2 |
P.B./ Cell fraction & serum | 3 | 8 |
Technique | ||
AGID assay | 3 | 6.8 |
Complement fixation test | 1 | 2.3 |
ELISA | 4 | 9 |
IHC | 3 | 6.8 |
Immunoblotting | 1 | 2.3 |
Immunoperoxidase | 1 | 2.3 |
Nested PCR | 13 | 29.5 |
Nested PCR & Nested In situ PCR | 1 | 2.3 |
PCR | 6 | 13.6 |
PCR In situ | 7 | 15.9 |
qPCR | 1 | 2.3 |
Southern blot | 1 | 2.3 |
WSG | 2 | 4.5 |
Target | ||
env | 8 | 13 |
gag | 12 | 19 |
tax | 16 | 26 |
pol | 5 | 8 |
px | 1 | 2 |
LTR | 4 | 6 |
WSG | 1 | 2 |
gp51 | 4 | 6 |
p24 | 6 | 10 |
Not specified | 5 | 8 |
P.B.: Peripherally blood, BTFFP: Breast tissue specimen fixed in neutral formalin and embedded in paraffin, B.M.: Bone marrow, WSG: Whole genome sequencing, IHC: Immunohistochemistry, AGID: Agar gel immunodiffusion, ELISA: Enzyme-Linked ImmunoSorbent Assay, PCR: Polymerase Chain Reaction.